Fungal Infections
- Achkar JM, Fries BC. Candida infections of the genitourinary tract. Clin Microbiol Rev 2010;23:253.
- Anon. Wide variety of topical treatments for tinea infections. Drugs Ther Perspect 1999;13:10-3.
- Anon. Antifungal drugs. Med Lett Treatment Guidelines 2009;7:95-102.
- Anon. Drugs for vulvovaginal candidiasis. Med Lett 2001;43:3-4.
- Berker D. Fungal nail disease. N Engl J Med 2009;360:2108-16.
- Bourlond A, Lachapelle JM, Aussems J, et al. Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea corporis and tinea cruris. Int J Dermatol 1989;28:410-2.
- Bow EJ, Evans G, Fuller J, et al. Canadian clinical practice guidelines for invasive candidiasis in adults. Can J Infect Dis Med Microbiol 2010;21:122-50.
- Brautigam M, Nolting S, Schopf RE, et al. German randomized double-blind multicentre comparison of terbinafine and itraconazole for the treatment of toenail tinea infection. Br J Dermatol 1996;134:18-21.
- Breazzano MP, Day HR Jr, Bloch KC, et al. Utility of ophthalmologic screening for patients with Candida bloodstream infections: a systematic review. JAMA Ophthalmol. doi:10.1001/jamaophthalmol.2019.0733
- Brown, SJ. Efficacy of fluconazole for the treatment of onychomycosis. Ann Pharmacother 2009;43:1684-91.
- Chapman SW, Bradsher RW, Campbell, Jr GD, et al. Practice guidelines for the management of patients with blastomycosis. Clin Infect Dis 2000;30:679-83.
- Chapman SW, Dismukes WE, Proia LA, et al. Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis 2008;46:1801-12.
- Cox GM, Perfect JR. Fungal rhinosinusitis. Up-to-Date 2010. Accessed May 16, 2012.
- Crissey JT. Common dermatophyte infections. Postgrad Med 1998;103:191-205.
- De Backer M, De Keyser P, De Vroey P, et al. A 12-week treatment for dermatophyte toe onychomycosis: terbinafine 250mg/day vs. itraconazole 200mg/day – a double blind comparative trial. Br J Dermatol 1996;134:16-7.
- Delescluse J. Itraconazole in tinea versicolor: a review. J Am Acad Dermatol 1990;23:551-4.
- Denning DW. Invasive aspergillosis. Clin Infect Dis 1998;26:781-805.
- Deresinski S. Candidemia: Does every patient need a complete retinal examination by an ophthalmologist? Editorial-In the Literature Clin Infect Dis 2019;69:iii. https://academic.oup.com/cid/article/69/8/iii/5574695
- Dragos V, Lunder M. Lack of efficacy of 6 week treatment with oral terbinafine for tinea capitis due to Microsporum canis in children. Pediatr Dermatol 1997;14:46-8.
- Drake LA, Dinehart SM, Farmer ER, et al. Guidelines of care for superficial mycotic infections of the skin: tinea corporis, tinea cruris, tinea faciei, tinea manuum, and tinea pedis. J Am Acad Dermatol 1996;34:282-6.
- Drake LA, Dinehart SM, Farmer ER, et al. Guidelines of care for superficial mycotic infections of the skin: pityriasis (tinea) versicolor. J Am Acad Dermatol 1996;34:287-9.
- Drake LA, Dinehart SM, Farmer ER, et al. Guidelines of care for superficial mycotic infections of the skin: tinea capitis and tinea barbae. J Am Acad Dermatol 1996;34:290-4.
- Edwards JEJ, Bodey GP, Bowden RA, et al. International conference for the development of a consensus on the management and prevention of severe candidal infections. Clin Infect Dis 1997;25:43-59.
- Filho ST, Cuce LC, Foss NT. Efficacy, safety and tolerability of terbinafine for tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1,2, and 4 weeks. J Eur Acad Dermatol Venereol 1998;11:141-6.
- Fisher JF. Infections - epidemiology, pathogenesis, diagnoses, and treatment: Executive summary. Clin Infect Dis 2011;52:429-32.
- Fisher JF, Sobel JD, Kauffman CA, et al. Candida urinary tract infections - treatment. Clin Infect Dis 2011;52:457-66.
- Galgiani JN, Ampel NM, Blair JE, et al. Coccidioidomycosis. Clin Infect Dis 2005;41:1217-23.
- Galgiani JN, Ampel NM, Catanzaro A, et al. Practice guidelines for the treatment of coccidioidomycosis. Clin Infect Dis 2000;30:658-61.
- Griswold M, Briceland L, Stein D. Is amphotericin B test dosing needed? Ann Pharmacother 1998;32:475-77.
- Gruseck E, Splanemann V, Bleck O, et al. Oral terbinafine in tinea capitis in children. Mycoses 1996;39:237-40.
- Gupta AK, Einarson TR, Summerbell RC, et al. An overview of topical antifungal therapy in dermatomycoses. Drugs 1998;55:645-74.
- Hernanz A, Gomez SL, Lastra FG, et al. A comparative double-blind study of terbinafine (Lamisil) and griseofulvin in tinea corporis and tinea cruris. Clin Exp Dermatol 1990;15:210-6.
- Hickman JG. A double-blind, randomized, placebo-controlled evaluation of short-term treatment with oral itraconazole in patients with tinea versicolor. J Am Acad Dermatol 1996;34:785-7.
- Hofmann H, Brautigam M, Weidinger G, et al. Treatment of toenail onychomycosis: a randomized, double-blind study with terbinafine and griseofulvin. Arch Dermatol 1995;131:919-22.
- Izumikawa K, Takazono T, Kohno S. Chronic aspergillus infections of the respiratory tract: diagnosis, management and antifungal resistance. Curr Opin Infect Dis 2010;28:584-9.
- Johnson MD, MacDougall C, Ostrosky-Zeichner L, et al. Combination antifungal therapy. Antimicrob Agents Chemother 2004;48:693-715.
- Kauffman CA, Bustamante B, Chapman SW, et al. Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis 2007;45:1255-65.
- Kauffman CA, Hajjeh R, Chapman SW. Practice guidelines for the management of patients with sporotrichosis. Clin Infect Dis 2000; 30:684-7.
Kim BJ. Utility of ophthalmic consultations for patients with candidemia. JAMA Ophthalmol 2019;137:698-710. https://pubmed.ncbi.nlm.nih.gov/30998822/
- Kulberg BJ, Verweij PE, Akova M, et al. European expert opinion on the management of invasive candidiasis in adults. Clin Microbiol Infect 2011;17:1-12.
- Lachapelle JM, DeDoncker P, Tennstedt D, et al. Itraconazole compared with griseofulvin in the treatment of tinea corporis/cruris and tinea pedis/manus: an interpretation of the clinical results of all completed double-blind studies with respect to the pharmacokinetic profile. Dermatology 1992;184:45-50.
- Laupland KB, Gregson DB, Church DL, et al. Invasive Candida species infections: a 5 year population-based assessment. J Antimicrob Chemother 2005;56:532-7.
- Legendre R, Esola-Macre J. Itraconazole in the treatment of tinea capitis. J Am Acad Dermatol 1990;23:559-60.
- Lewis RE, Klepser ME. The changing face of nosocomial candidemia: epidemiology, resistance, and drug therapy. Am J Health-Syst Pharm 1999;56:525-36.
- Limper AH, Knox KS, Sarosi GA et al. An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med 2011;183:96-128.
- Marr KA, Boeckh M, Carter RA, et al. Combination antifungal therapy for invasive aspergillosis. Clin Infect Dis 2004;39:797-802.
- Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009;48:503-35.
- Pappas PG, Rex JH, Sobel JD, et al. Guidelines for treatment of candidiasis. Clin Infect Dis 2004;38:161-89.
- Pappas PG, Rotstein CMF, Betts RF, et al. Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis. Clin Infect Dis 2007;45:883-93.
- Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008;46:1813-21.
- Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2010;50:291-322.
- Restrepo A, Robledo J, Gomez I, et al. Itraconazole therapy in lymphangitic and cutaneous sporotrichosis. Arch Dermatol 1986;122:413-7.
- Rex JH, Bennett JE, Sugar AM, et al. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med 1994;331:1325-30.
- Rex JH, Pappas PG, Karchmer AW, et al. A randomized and blinded trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects. Clin Infect Dis 2003;36:1221-8.
- Saag MS, Graybill RJ, Larsen RA, et al. Practice guidelines for the management of cryptococcal disease. Clin Infect Dis 2000;30:710-8.
- Schwartz S, Ruhnke M, Ribaud P, et al. Improved outcome in central nervous system aspergillosis, using voriconazole treatment. Blood 2005;106:2641-5.
- Segal BH. Aspergillosis. N Engl J Med 2009;360:1870-84.
- Segal BH, Walsh TJ. Current approaches to diagnosis and treatment of invasive aspergillosis. Am J Respir Crit Care Med 2006;173:707-17.
- Sharkey-Mathis PK, Kauffman CA, Graybill JR, et al. Treatment of sporotrichosis with itraconazole. Am J Med 1993;95:279-85.
- Sheehan DJ, Hitchcock CA, Sibley CM. Current and emerging azole antifungal agents. Clin Microbiol Rev 1999;12:40-79.
- Sobel JD. Practice guidelines for the treatment of fungal infections. Clin Infect Dis 2000;30:652.
- Stevens DA, Kan VL, Judson MA, et al. Practice guidelines for diseases caused by Aspergillus. Clin Infect Dis 2000;30:696-709.
- Stevens DA, Kan VL, Judson MA, et al. Practice guidelines for diseases caused by Aspergillus. Clin Infect Dis 2000;30:696-709.
- Tom CM, Kane MP. Management of toenail onychomycosis. Am J Health-Syst Pharm 1999;56:865-71.
- Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008;46:327-60.
- Wheat LJ, Freifeld AG, Kleiman MB, et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Dieases Society of America. Clin Infect Dis 2007:45:807-25.
- Wheat J, Sarosi G, McKinsey D, et al. Practice guidelines for the management of patients with histoplasmosis. Clin Infect Dis 2000;30:688-95.
- Yamamura DLR, Rotstein C, Nicolle LE, et al. Candidemia at selected Canadian sites: results from the Fungal Disease Registry, 1992-1994. CMAJ 1999;160:493-9.
Pneumocystis Pneumonia
- Krajicik BJ, Thomas CF, Limper AH. Pneumocystis pneumonia: current concepts in pathogenesis, diagnosis and treatment. Clin Chest Med 2009:30;265-78.